Patents Assigned to Chemagis Ltd.
  • Publication number: 20100184988
    Abstract: The present invention provides processes for producing isoquinolinium compounds, and for converting them into cisatracurium salts, e.g.
    Type: Application
    Filed: May 1, 2008
    Publication date: July 22, 2010
    Applicant: CHEMAGIS LTD.
    Inventors: Vladimir Naddaka, Shen Jingshan, Oded Arad, Guo Hongli, Ofer Sharon, Eyal Klopfer, Shady Saeed
  • Publication number: 20100174082
    Abstract: The present invention provides an improved method for obtaining cisatracurium besylate, which preferably chromatographically separating cisatracurium besylate from a mixture of (1R,1?R)-atracurium isomers via flash chromatography
    Type: Application
    Filed: March 5, 2008
    Publication date: July 8, 2010
    Applicant: Chemagis Ltd.
    Inventors: Oded Arad, Elena Ostrovsky
  • Publication number: 20100174080
    Abstract: Provided are novel salts of 2-(1-azabicyclo-[2.2.
    Type: Application
    Filed: May 28, 2008
    Publication date: July 8, 2010
    Applicant: CHEMAGIS LTD.
    Inventors: Tang Wensheng, Zhang Xingzhong, He Xungui, Yuan Wang, Joseph Kaspi
  • Publication number: 20100168431
    Abstract: The present invention provides novel isoquinolinium compounds, methods of producing the isoquinolinium compounds, and methods for converting them into cisatracurium, e.g., cisatracurium besylate.
    Type: Application
    Filed: May 1, 2008
    Publication date: July 1, 2010
    Applicant: Chemagis Ltd.
    Inventors: Vladimir Naddaka, Shen Jingshan, Oded Arad, Guo Hongli, Ofer Sharon, Eyal Klopfer, Shady Saeed
  • Patent number: 7745471
    Abstract: Derivatives of 1,2-benzisoxazole-3-methanesulfonic acid, which are non-hygroscopic and non-hydrated and their use as intermediates from the preparation of zonisamide are disclosed. Further disclosed are processes of preparing zonisamide from these 1,2-benzisoxazole-3-methanesulfonic acid derivatives, processes of preparing exemplary 1,2-benzisoxazole-3-methanesulfonic acid derivatives and crystalline forms of exemplary 2-benzisoxazole-3-methanesulfonic acid derivatives. A novel process of preparing zonisamide is also disclosed.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: June 29, 2010
    Assignee: Chemagis Ltd.
    Inventors: Vladimir Naddaka, Eyal Klopfer, Shady Saeed, Oded Arad, Joseph Kaspi
  • Publication number: 20100099878
    Abstract: The present invention provides an improved method of chromatographically separating the isomers of (1R,rR)-atracurium salts by high-performance liquid chromatography (HPLC), in the absence of a strong acid. The separation is preferably performed on a silica gel HPLC column using an eluent containing an organic solvent, a polar aprotic co-solvent and a weak organic acid.
    Type: Application
    Filed: March 5, 2008
    Publication date: April 22, 2010
    Applicant: Chemagis Ltd.
    Inventors: Oded Arad, Elena Ostrovsky
  • Publication number: 20100087650
    Abstract: Provided is a method for separating cisatracurium from a mixture of atracurium isomers, which method includes eluting from a Reverse Phase (RP) stationary phase with a mobile phase in which the isomers are stable. The method of the present invention can be conveniently and inexpensively scaled up.
    Type: Application
    Filed: March 5, 2008
    Publication date: April 8, 2010
    Applicant: CHEMAGIS LTD.
    Inventors: Elena Ostrovsky, Oded Arad
  • Patent number: 7659398
    Abstract: The present invention provides a process for preparing highly pure 4-amino-1-isobutyl-1H-imidazo[4,5-c]quinoline (imiquimod). The process preferably includes heating 4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline of formula (II) with ammonia in a polar aprotic solvent at relatively moderate pressure to produce imiquimod, and optionally purifying the imiquimod. The process of the present invention can produce highly pure imiquimod in high yield.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: February 9, 2010
    Assignee: Chemagis Ltd.
    Inventors: Vladimir Naddaka, Shady Saeed, Stephen Cherkez, Oded Arad
  • Publication number: 20100022609
    Abstract: Disclosed are novel crystalline forms of Temozolomide, methods of preparation thereof, medicaments including the novel crystalline forms of Temozolomide, and uses thereof in the treatment of medical conditions.
    Type: Application
    Filed: August 12, 2009
    Publication date: January 28, 2010
    Applicant: CHEMAGIS LTD.
    Inventors: Itai Adin, Carmen Iustain
  • Patent number: 7615632
    Abstract: Disclosed are novel crystalline forms of Temozolomide, methods of preparation thereof, medicaments including the novel crystalline forms of Temozolomide, and uses thereof in the treatment of medical conditions.
    Type: Grant
    Filed: December 30, 2004
    Date of Patent: November 10, 2009
    Assignee: Chemagis Ltd.
    Inventors: Itai Adin, Carmen Iustain
  • Patent number: 7612202
    Abstract: The present invention provides a process for preparing highly pure Temozolomide base which includes recovery from the purification mother liquors by using an anionic exchange resin. By treating Temozolomide hydrochloride with a mixture of an organic acid, a water miscible organic solvent, and water, Temozolomide free base is obtained in an acidic medium. Due to the high sensitivity of Temozolomide to basic pH values the recovery-including process is especially advantageous because it enables obtaining high yields of highly pure Temozolomide base in acidic conditions. The process for producing Temozolomide base includes hydrolysis of the starting material 8-cyano-3-methyl-[3H]-imidazo[5,1-d]-tetrazin-4-one in acidic medium to obtain highly pure Temozolomide hydrochloride in high yield.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: November 3, 2009
    Assignee: Chemagis, Ltd.
    Inventors: Olga Etlin, Mohammed Alnabari, Yana Sery, Edna Danon, Oded Arad, Joseph Kaspi
  • Patent number: 7592459
    Abstract: The present invention provides a crystalline donepezil maleate, which is used as an intermediate in the preparation of donepezil hydrochloride. Also provided are novel processes for producing same in substantially pure form and a process for producing pharmaceutically pure amorphous donepezil hydrochloride therefrom.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: September 22, 2009
    Assignee: Chemagis Ltd.
    Inventors: Oded Arad, Lior Zelikovitch, Mohammed Alnabari, Michael Brand, Irina Gribun, Ada Salman, Meital Shiffer, Moty Shookrun, Orna Kurlat, Moshe Bentolila, Joseph Kaspi
  • Publication number: 20090221811
    Abstract: The present invention provides processes for preparing intermediates useful in the preparation of gemcitabine and other nucleosides, and processes for preparing gemcitabine therewith. Exemplary intermediates include mixtures of D-erythro and D-threo isomers of 3-(hydroxy)-2,2-difluoro-3-(2,2-dimethyldioxolan-4-yl)-propionic acid salts. Also provided is a process for selectively isolating the D-erythro and D-threo isomers of D-erythro and D-threo isomers of 3-(hydroxy)-2,2-difluoro-3-(2,2-dimethyldioxolan-4-yl)-propionic acid salts, and processes for using such isomers in the preparation of nucleoside analogs such as, e.g., gemcitabine, intermediates thereof, and analogs thereof.
    Type: Application
    Filed: April 27, 2009
    Publication date: September 3, 2009
    Applicant: CHEMAGIS LTD.
    Inventors: Vladimir NADDAKA, Eyal KLOPFER, Shady SAEED, Dionne MONTVILISKY, Oded ARAD, Joseph KASPI
  • Patent number: 7579461
    Abstract: A novel process for preparing (2?,3?,5?,16?,17?)-17-acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl) androstane, a known intermediate in the synthesis of the skeletal muscle relaxant rocuronium bromide, is disclosed.
    Type: Grant
    Filed: January 13, 2005
    Date of Patent: August 25, 2009
    Assignee: Chemagis Ltd.
    Inventors: Eliezer Adar, David Sondack, Oded Friedman, Iosef Manascu, Tamir Fizitzki, Boris Freger, Oded Arad, Alexander Weisman, Joseph Kaspi
  • Patent number: 7572930
    Abstract: The present invention provides a novel montelukast intermediate and a simple and straightforward process for preparing it. According to the present invention, by using this intermediate and the process, essentially as described herein, montelukast acid and salts thereof are obtained.
    Type: Grant
    Filed: February 1, 2007
    Date of Patent: August 11, 2009
    Assignee: Chemagis Ltd.
    Inventors: Yanling Wang, Yuang Wang, Michael Brand, Joseph Kaspi
  • Patent number: 7550591
    Abstract: Provided is a process for producing imatinib and salts thereof, e.g., imatinib mesylate. The process includes reacting 4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid with N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine in the presence of a carboxylic acid coupling reagent, to produce imatinib, and optionally converting the imatinib into a salt.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: June 23, 2009
    Assignee: Chemagis Ltd.
    Inventors: Liu Xing, He Xungui, Yuan Wang, Michel Bekhazi, Sonia Krivonos, Edna Danon
  • Patent number: 7544805
    Abstract: An amorphous form of montelukast sodium and a montelukast sodium lactose co-precipitate, processes for producing same, pharmaceutical compositions containing same and methods of treatment utilizing same are disclosed.
    Type: Grant
    Filed: February 3, 2005
    Date of Patent: June 9, 2009
    Assignee: Chemagis Ltd.
    Inventors: Mohammed Alnabari, Yana Sery, Itai Adin, Oded Arad, Joseph Kaspi
  • Patent number: 7538230
    Abstract: Provided is a method for preparing letrozole, which includes reacting an activated bis-(4-cyanophenyl)-methane with a triazole to produce letrozole, and, optionally, purifying the letrozole. Also provided are highly pure letrozole, and a method of purifying letrozole, which method includes precipitating letrozole, e.g., by selective precipitation from a reaction mixture and/or by subjecting the letrozole to one or more crystallizations.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: May 26, 2009
    Assignee: Chemagis Ltd.
    Inventors: Oded Friedman, Boris Freger, Olga Etlin, Julia Ditkovitch, Edna Danon, Yana Seryi, Guy Davidi, Oded Arad, Joseph Kaspi
  • Patent number: 7528254
    Abstract: The present invention provides a process for preparing highly pure montelukast and salts thereof by reacting the side-chain precursor 1-(mercaptomethyl)-cyclopropaneacetic acid with 2-(2-(3S)-(3-(7-chloro-2-quinolinyl)-ethenyl)phenyl)-3-(methanesulfonyloxypropyl)phenyl-2-propanol in a solvent mixture containing a base.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: May 5, 2009
    Assignee: Chemagis Ltd.
    Inventors: Michael Brand, Moty Shookrun, Oded Arad, Joseph Kaspi
  • Patent number: 7524960
    Abstract: A novel process for preparing highly pure cilostazol, effected by reacting 6-hydroxy-3,4-dihydroquinolinone and 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole in the presence of a hydrated inorganic base, is disclosed. Further disclosed is highly pure cilostazol, and particularly highly pure cilostazol that is substantially free of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butyl ]-3,4-dihydro-1H-quinolin-2-one.
    Type: Grant
    Filed: March 16, 2005
    Date of Patent: April 28, 2009
    Assignee: Chemagis Ltd.
    Inventors: Vladimir Naddaka, Guy Davidi, Shady Saeed, Oded Arad, Joseph Kaspi